Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Anthony M MillsLaurence BrunetJennifer S FuscoMichael B WohlfeilerCindy P GarrisAlan K OglesbyJoseph M MrusPhilip C LackeyGregory P FuscoPublished in: Infectious diseases and therapy (2019)
ViiV Healthcare.